Since inhibition of oncogenic BRAFV600E signaling in melanoma cells decreased POLR2A stability, we investigated whether the RNA polymerase II inhibitor α-amanitin might exhibit synergistic effects in combination with PLX4720. This evidence concerns the gene POLR2A and melanoma.